Who is sponsoring NCT04957953?

NCT04957953 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT04957953?

Interventions in NCT04957953: Patient's consent, Inclusion form, Adverse reaction report form., Follow-up report form..

What condition does NCT04957953 study?

NCT04957953 studies Pregnant Women Vaccinated Against Covid-19.

Is NCT04957953 still recruiting?

NCT04957953 is currently completed. Last updated 27 March 2023.

Last reviewed 2023-03-27 · How we verify

NCT04957953: COVACPREG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pregnant Women Vaccinated Against Covid-19.

Completed Last updated 27 March 2023

What this trial tests

trial testing Patient's consent in Pregnant Women Vaccinated Against Covid-19 in 1,393 participants. Completed in 13 December 2022.

Timeline

2 December 2021

Primary endpoint
13 December 2022

13 December 2022

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,393
Start date	2 December 2021
Primary completion	13 December 2022
Estimated completion	13 December 2022
Sites	1 location across France

Drugs / interventions tested

Patient's consent
Inclusion form
Adverse reaction report form.
Follow-up report form.

Conditions studied

Pregnant Women Vaccinated Against Covid-19 — all drugs for Pregnant Women Vaccinated Against Covid-19 →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 18 to 60, female only, with Pregnant Women Vaccinated Against Covid-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Establish a cohort of pregnant women exposed to a COVID19 vaccine, whether or not they have experienced an adverse event, to assess the potential effects of vaccines on the course of pregnancy, on the fetus or newborn and on the mother.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Associations of COVID-19 vaccination during pregnancy with adverse neonatal and maternal outcomes: A systematic review and meta-analysis.
Ding C, Liu Y, Pang W, Zhang D, et al · · 2023 · cited 17× · PMID 36794075 · DOI 10.3389/fpubh.2023.1044031

Verify or expand the search:

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04957953 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 27 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04957953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing